Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2580 to 2629 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
katanin p80 subunit b 1; katanin (80 kda); katanin p80 (wd40-containing) subunit b 1. [source:refseq;acc:nm\_005886]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4331.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4252.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01848\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 19 kda polypeptide (ec 2.7.7.6) (rpb7). [source:swissprot;acc:p52433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4570.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4654.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01841\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 23 kda polypeptide (ec 2.7.7.6) (rpb25) (xap4) (rpb5) (rpabc1). [source:swissprot;acc:p19388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3899.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3829.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01821\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (32kd). [source:refseq;acc:nm\_006467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3926.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3857.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01776\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deformed epidermal autoregulatory factor 1 homolog (nuclear deaf-1 related transcriptional regulator) (nudr) (suppressin) (zinc finger mynd domain containing protein 5). [source:swissprot;acc:o75398]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4180.32\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4253.46\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0175\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rio kinase 1 isoform 1; ad034 protein. [source:refseq;acc:nm\_031480]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 1. [source:refseq;acc:nm\_018650]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 2 isoform b; elkl motif kinase 1; elkl motif kinase. [source:refseq;acc:nm\_004954]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
meiotic recombination protein spo11. [source:swissprot;acc:q9y5k1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7181.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7057.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01747\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 5 (heterochromatin protein 1 homolog alpha) (hp1 alpha) (antigen p25). [source:swissprot;acc:p45973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7551.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7422.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01741\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 3 (heterochromatin protein 1 homolog gamma) (hp1 gamma) (modifier 2 protein) (hech). [source:swissprot;acc:q13185]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7550.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7422.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01726\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translationally controlled tumor protein (tctp) (p23) (histamine- releasing factor) (hrf). [source:swissprot;acc:p13693]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7169.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7047.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01717\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp41 (ec 3.1.13.-) (ribosomal rna processing protein 41) (p12a). [source:swissprot;acc:q9npd3]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4921.84\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5005.06\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01691\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp4 (ec 3.1.13.-) (ribosomal rna processing protein 4). [source:swissprot;acc:q13868]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp40 (ec 3.1.13.-) (ribosomal rna processing protein 40) (p10) (cgi-102). [source:swissprot;acc:q9nqt5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp46 (ec 3.1.13.-) (ribosomal rna processing protein 46) (p12b) (chronic myelogenous leukemia tumor antigen 28). [source:swissprot;acc:q9nqt4]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 2 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 2). [source:swissprot;acc:p51669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8104.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7970.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01689\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 1 (heterochromatin protein 1 homolog beta) (hp1 beta) (modifier 1 protein) (m31) (heterochromatin protein p25). [source:swissprot;acc:p23197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7538.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7417.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0163\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanyl-trna synthetase (ec 6.1.1.7) (alanine--trna ligase) (alars). [source:swissprot;acc:p49588]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4367.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4438.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01627\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrolipoamide dehydrogenase, mitochondrial precursor (ec 1.8.1.4) (glycine cleavage system l protein). [source:swissprot;acc:p09622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6185\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6283.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01597\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad50 homolog isoform 1. [source:refseq;acc:nm\_005732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7222.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7110.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01566\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim/homeobox protein lhx3. [source:swissprot;acc:q9ubr4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7571.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7688.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01541\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain binding 2; lim binding domain 2; lim domain-binding factor-2. [source:refseq;acc:nm\_001290]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7572.69\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7689.04\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01536\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain binding 1; carboxy terminal lim domain protein 2; lim domain-binding factor-1. [source:refseq;acc:nm\_003893]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7572.7\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim/homeobox protein lhx4. [source:swissprot;acc:q969g2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7573.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7689.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01531\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosyl-trna synthetase (ec 6.1.1.1) (tyrosyl--trna ligase) (tyrrs). [source:swissprot;acc:p54577]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4450.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4517.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01499\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal interaction molecule 1 precursor. [source:swissprot;acc:q13586]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.19\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01498\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trap/mediator complex component trap25. [source:refseq;acc:nm\_080651]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.18\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd repeat- and fyve domain-containing protein 2; wd40 and fyve domain containing 2. [source:refseq;acc:nm\_052950]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.41\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 4 (ec 2.7.1.-) (p21-activated kinase 4) (pak-4). [source:swissprot;acc:o96013]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.19\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyposis locus protein 1 (tb2 protein). [source:swissprot;acc:q00765]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.18\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2612\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, medium-chain specific, mitochondrial precursor (ec 1.3.99.3) (mcad). [source:swissprot;acc:p11310]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.19\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyposis locus protein 1-like 1; likely ortholog of mouse polyposis locus protein 1-like 1. [source:refseq;acc:nm\_138393]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6476.18\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal interaction molecule 2 precursor. [source:swissprot;acc:q9p246]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6380.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6476.19\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 7 (ec 2.7.1.-) (p21-activated kinase 7) (pak-7) (pak-5). [source:swissprot;acc:q9p286]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd repeat and fyve domain containing 1 isoform 1; phosphoinositide-binding protein sr1; wd40 and fyve domain containing 1. [source:refseq;acc:nm\_020830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6380.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.92\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 4 (heat shock 40 kda protein 1 homolog) (heat shock protein 40 homolog) (hsp40 homolog). [source:swissprot;acc:q9udy4]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5599.85\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5683\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01485\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cab2. [source:refseq;acc:nm\_033419]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 5 (heat shock protein hsp40-3) (heat shock protein cognate 40) (hsc40) (hsp40-2). [source:swissprot;acc:o75953]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 1 (heat shock 40 kda protein 1) (heat shock protein 40) (hsp40) (dnaj protein homolog 1) (hdj-1). [source:swissprot;acc:p25685]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic peptide chain release factor subunit 1 (erf1) (eukaryotic release factor 1) (tb3-1) (c11 protein). [source:swissprot;acc:p46055]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of actin mutations 2-like isoform b; dj1033b10.5. [source:refseq;acc:nm\_022553]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 3 beta 1 subunit (beta-adaptin 3a) (ap-3 complex beta-3a subunit) (beta-3a-adaptin). [source:swissprot;acc:o00203]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6815.24\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6916.14\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01481\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ny-ren-24 antigen (fragment). [source:sptrembl;acc:q9y5a4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 3 beta 2 subunit (beta-adaptin 3b) (ap-3 complex beta-3b subunit) (beta-3b-adaptin) (neuron-specific vesicle coat protein beta-nap). [source:swissprot;acc:q13367]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
insulin gene enhancer protein isl-1 (islet-1). [source:swissprot;acc:p20663]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7424.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7534.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01479\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2627\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-specific protease otubain 1. [source:refseq;acc:nm\_017670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7135.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7240.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0147\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2628\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s9. [source:swissprot;acc:p46781]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3933.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3877.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0146\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2629\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 14.4 kda polypeptide (ec 2.7.7.6) (rpb6) (rpb14.4) (rpabc2). [source:swissprot;acc:p41584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4582.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4649.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01458\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/